What is ctHPV- DNA biomarker?
Is it currently available in clinic? How can it impact the treatment journey of patients suffering from HPV-associated cancers?
The following blog series will deep dive in answering these questions to help you understand how this biomarker can potentially transform treatment management of HPV-associated cancers.
Whether you are a healthcare provider, a pharma or precision medicine expert or a patient or caregiver directly impacted by HPV-associated cancers, if you would like to keep yourself abreast on the latest information on this biomarker, our blog is well worth reading.